Paxil Birth Defect Lawyers
Paxil—also known as paroxetine—is a selective serotonin reuptake inhibitor (SSRI) antidepressant that’s prescribed to treat conditions like major depression, obsessive-compulsive disorder, social anxiety, post-traumatic stress disorder, and more.
The American College of Obstetricians and Gynecologists recommends that women who are pregnant or plan on becoming pregnant avoid taking Paxil and other SSRIs. And in 2012, the U.S. Food and Drug Administration published a medication guide warning healthcare providers and patients of the correlation between Paxil and heart problems in developing fetuses that are exposed to the drug.
Types of Paxil Birth Defects
Birth defects associated with use of SSRIs like Paxil may include:
Babies who are exposed to Paxil while in the womb have a higher risk of developing heart defects—including holes in the walls of their heart chambers—than babies who weren’t exposed to the drug. Children with this condition may require surgery to correct the heart defects.
Anencephaly is characterized by an incomplete growth of the top of the skull and brain in babies. This condition may be present in babies who are exposed to SSRIs like Paxil. Children with this condition have a low survival rate outside the womb.
At Ferrer, Poirot & Wansbrough, we know that these conditions can lead to severe health problems, expensive medical treatments, and even death. If you took Paxil and your child was born with a birth defect, our Paxil injury lawyers want to help you get the compensation you deserve for your child’s medical bills. Contact us at (800) 210-8503 or fill out a free initial consultation form.
How We Can Help
The Paxil lawyers at Ferrer, Poirot & Wansbrough are dedicated to standing up for the rights of families who have suffered because of a drug manufacturer’s negligence. It’s our goal to give a voice to victims of prescription drugs. Let us put our experience to work for you—call today.
Paxil® is a registered trademark of GlaxoSmithKline.
This law firm is not associated with, sponsored by, or affiliated with GlaxoSmithKline, the U.S. Food and Drug Administration or The American College of Obstetricians and Gynecologists.